Extracellular vesicles released within the aging bone marrow niche carry altered microRNA profiles and diminished antioxidant content, propagating senescence and pushing blood stem cells toward myeloid-biased, inflammation-prone output. Vesicles derived from young or pluripotent stem cells reverse aspects of this decline, restoring aged progenitor function and reducing chronic low-grade inflammation. Because vesicle cargo reflects niche status, circulating vesicles function simultaneously as a biomarker of hematopoietic age and a candidate therapeutic vector.
Key Points
- Aged bone marrow vesicles transmit senescence and pro-inflammatory microRNA cargo
- Youthful stem cell vesicles restore aged progenitor function, reduce inflammaging
- Surface tetraspanins and integrins determine which blood cells receive signals
Longevity Analysis
Immune competence and blood cell renewal decline in a directed, message-driven manner rather than through passive wear, and the messages originate in the stromal environment surrounding the stem cells. Targeting the cargo that maintains chronic low-grade inflammation addresses an upstream interference signal rather than its downstream consequences in defense capacity and tissue repair. Vesicle profiling also offers a measurable window into how accurately the marrow niche is communicating with the cells it governs, which is prerequisite information before any rejuvenation strategy can be applied with precision.
Original published by Wiley Aging Cell, by Esra G. Kosebent, Nathalie Havranek, Karoline Kollmann, Kristina Kirschner, Eszter Doma, Kavya Gupta .